Mapping the genomic landscape of CRISPR–Cas9 cleavage-Reference-Cited by-同舟云学术

Mapping the genomic landscape of CRISPR–Cas9 cleavage

Published:2017-05-01 Issue:6 Volume:14 Page:600-606
ISSN:1548-7091
Container-title:Nature Methods
language:en
Short-container-title:Nat Methods

Author:

Cameron Peter,Fuller Chris K,Donohoue Paul D,Jones Brittnee N,Thompson Matthew S,Carter Matthew M,Gradia Scott,Vidal Bastien,Garner Elizabeth,Slorach Euan M,Lau Elaine,Banh Lynda M,Lied Alexandra M,Edwards Leslie S,Settle Alexander H,Capurso Daniel,Llaca Victor,Deschamps Stéphane,Cigan Mark^ORCID,Young Joshua K,May Andrew P

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Biochemistry,Biotechnology

Link

http://www.nature.com/articles/nmeth.4284.pdf

Reference34 articles.

1. Hsu, P.D., Lander, E.S. & Zhang, F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262–1278 (2014).

2. Doudna, J.A. & Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096 (2014).

3. Sternberg, S.H. & Doudna, J.A. Expanding the biologist's toolkit with CRISPR-Cas9. Mol. Cell 58, 568–574 (2015).

4. Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012).

5. Gasiunas, G., Barrangou, R., Horvath, P. & Siksnys, V. Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. USA 109, E2579–E2586 (2012).

Cited by 346 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene editing of angiotensin for blood pressure management;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-12

2. Combining Off‐flow, a Nextflow‐coded program, and whole genome sequencing reveals unintended genetic variation in CRISPR/Cas-edited iPSCs;Computational and Structural Biotechnology Journal;2024-12

3. Learning to quantify uncertainty in off-target activity for CRISPR guide RNAs;Nucleic Acids Research;2024-09-14

4. Overcoming CRISPR-Cas9 off-target prediction hurdles: A novel approach with ESB rebalancing strategy and CRISPR-MCA model;PLOS Computational Biology;2024-09-03

5. Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis;Cell;2024-09